Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision metadata updated to show v3.5.0, replacing the older v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision stamp in the page footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No changes to study data, eligibility criteria, or navigation.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed, which are minor UI metadata changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now includes a glossary toggle and minor metadata and wording updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data capitalization, and Revision: v3.4.0) compared with the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.